TürkiyeDiagnosis and screening
Two new gene changes found in three families with achromatopsia in Türkiye
Eye and genetics doctors from Aydın and other provinces studied five patients with achromatopsia.
Eye and hearing diseases
An inherited disease in which the retinal cells responsible for color and daylight vision do not work. Colors are seen poorly or not at all. It comes with sensitivity to light and low vision.
Not part of the panel of Türkiye's National Newborn Screening Programme (heel-prick test). Source
This page is translated from the Turkish original.
This disease is followed through the “Eye and hearing diseases” group.
The retina has two kinds of light cells: rods and cones. Cones allow vision in daylight, color vision and sharp vision. In achromatopsia, the cones do not work at all or work very little. The disease usually does not progress; symptoms stay similar throughout life.
Symptoms begin in the first weeks after birth. The first thing noticed is usually shaking of the eyes.
The eye doctor tests sharpness of vision, color vision and the field of vision. An ERG test shows whether the cones respond to light. Imaging methods such as OCT show the structure of the retina. A genetic test supports the diagnosis.
There is no approved treatment at the moment. Care aims to ease the symptoms. Glasses with special filters, dark glasses or red-tinted lenses can reduce light sensitivity. Magnifiers and other low vision aids make reading easier. At school, it helps for the child to sit in the front row and away from the window. Eye checks are recommended every 6 to 12 months in childhood and every 2 to 3 years in adulthood. The doctor who follows the disease decides which treatment is suitable.
It is inherited recessively. For a carrier couple, the chance of an affected child in each pregnancy is 1 in 4. Carrier mothers and fathers usually have no symptoms. This chance can be higher when parents are related by blood. Girls and boys are affected equally often. Genetic counselling is recommended.
Source: MedlinePlus Genetics: Achromatopsia · NORD: Achromatopsia · Orphanet: Achromatopsia (ORPHA:49382)
These facts are taken from Orphanet and MedlinePlus records (last checked: October 7, 2026). Frequency values are approximate ranges.
Non-profit patient and family organizations in Türkiye working on this disease or disease group. Links are for information; Doktorclub is not affiliated with these organizations and does not endorse them.
We could not find a patient association specific to this disease.
For all rare diseases: Nadir Hastalıklar Federasyonu
Doktorclub does not diagnose, recommend treatments or refer you to hospitals or doctors. These pages are meant to help you talk with your doctor.
TürkiyeDiagnosis and screening
Eye and genetics doctors from Aydın and other provinces studied five patients with achromatopsia.
A clinical trial is a regulated study that tests whether a new treatment is safe and whether it works, in patients who volunteer. Most trials look for a certain age, genetic change and health condition. Taking part is voluntary.
Questions you can ask your doctor
ClinicalTrials.gov lists 1 active interventional study for this disease. None is recruiting right now; none has a site in Türkiye. Last checked: October 7, 2026.
Selected records (studies with a site in Türkiye first):
Middle stage: the effect is being tested in a small group · Phase 1 / Phase 2 · investigational (experimental)Active, not recruitingNCT02610582
See all studies on ClinicalTrials.gov · Joining clinical trials
TürkiyeSGK and reimbursement
A drug used for a rare disease affecting the optic nerve has been added to reimbursement coverage.
USAResearch and clinical trials
A two-year, placebo-controlled study was carried out at 7 centers in the USA.
TürkiyeResearch and clinical trials
Gazi University studied the eyes of 27 children.
These codes identify the disease in international classifications and databases. They can help when you talk with your doctor or look for reliable sources.
Orphanet code: ORPHA:49382
No separate ICD-11 code; WHO classifies this disease under: 9B70
Codes checked against WHO ICD-11 and Orphanet on October 7, 2026.
This page provides general information and does not replace diagnosis or treatment. Talk to your doctor about symptoms, diagnosis and treatment.